Lower Transplacental Antibody Transport for Measles, Mumps, Rubella and Varicella Zoster in Very Preterm Infants
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Maternal antibodies, transported over the placenta during pregnancy, contribute to the protection of infants from infectious diseases during the first months of life. In term infants, this protection does not last until the first recommended measles-mumps-rubella vaccination at 14 months in the Netherlands, while these viruses still circulate. The aim of the study was to investigate the antibody concentration against measles, mumps, rubella and varicella (MMRV) in mothers and preterm infants or healthy term infants at birth. METHODS: Antibody concentrations specific for MMRV were measured in cord blood samples from preterm (gestational age <32 weeks and/or birth weight <1500 g) and term infants, and matched maternal serum samples, using a fluorescent bead-based multiplex immune-assay. RESULTS: Due to lower placental transfer ratios of antibodies against MMRV in 96 preterm infants (range 0.75-0.87) compared to 42 term infants (range 1.39-1.65), the preterm infants showed 1.7-2.5 times lower geometric mean concentrations at birth compared to term infants. Maternal antibody concentration is the most important determinant of infant antibody concentration against MMRV. CONCLUSIONS: Preterm infants benefit to a lesser extent from maternal antibodies against measles, mumps, rubella and varicella than term infants, posing them even earlier at risk for infectious diseases caused by these still circulating viruses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unfortunately, preterm babies, especially those born < 34 weeks, have reduced levels of protective antibodies.”
From Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibody concentration has an impact on transplacental transfer8,25–27.”
From Transplacental transfer of total immunoglobulin G and antibodies to Plasmodium falciparum antigens between the 24th week of gestation and term (2022) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It follows therefore that a reduced transfer of IgG in preterm infants compared with term infants has been demonstrated for a variety of pathogens (97, 127, 128) particularly for infants born at less than 36 weeks of gestation (126).”
From Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy (2017) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Authority, E. F. S., & European Centre for Disease Prevention and Control (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3991 · Cited by 3,550
Morbidity and Mortality Weekly Report
(2011) · Wilderness & Environmental Medicine · doi:10.1016/j.wem.2010.11.007 · Cited by 3,423
Placental transport of immunoglobulin G
Simister, N. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00334-7 · Cited by 783
Measles Antibody: Reevaluation of Protective Titers
Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R., & Orenstein, W. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.5.1036 · Cited by 608 · cited 6×
“Protective concentrations for antimumps and anti-varicella antibodies are not internationally assigned, but locally assigned cut-off values of $45 RU/ml and $0.26 IU/ml, respectively, were used as previously described.”
InfluentialMcLean, H. Q., Fiebelkorn, A. P., Temte, J. L., & Wallace, G. S. (2013) · PubMed · Cited by 607
Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy
Malek, A., Sager, R., Kuhn, P., Nicolaides, K. H., & Schneider, H. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00172.x · Cited by 559 · cited 2×
“[7,8] While the fetal IgG is approximately 10% of the maternal concentration at 17–22 weeks of gestation, it increases to 50% at 28–32 weeks of gestation as determined by chordocentesis.[1,9] The increase of fetal IgG concentrations between 29 and 41 weeks of gestation is twice that at 17 to 28 weeks of gestation.”
BackgroundSiegrist, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00342-6 · Cited by 346 · cited 1×
“However T cell priming is not prevented by maternal antibodies.[45] Inhibition by maternal antibodies cannot be the only reason for low seroconversion, as both preterm and term infants lose their antibodies well before vaccination, even if the vaccination is given at 6–9 months instead of 12–14 months.”
BackgroundMeasles in Europe: an epidemiological assessment
Muscat, M., Bang, H., Wohlfahrt, J., Glismann, S., & Mølbak, K. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61849-8 · Cited by 219 · cited 5×
“[19,27] In the past 10 years, there were still outbreaks of measles with measles-related deaths all over Europe.”
BackgroundInfluentialTransplacental transport of IgG antibodies to preterm infants: A review of the literature
van den Berg, J. P., Westerbeek, E. A. M., van der Klis, F. R. M., Berbers, G. A. M., & van Elburg, R. M. (2011) · Early Human Development · doi:10.1016/j.earlhumdev.2010.11.003 · Cited by 212
Self-citationThe comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region
Nardone, A., de Ory, F., Carton, M., Cohen, D., van Damme, P., Davidkin, I., Rota, M. C., de Melker, H., Mossong, J., Slacikova, M., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.036 · Cited by 195 · cited 1×
“Varicella vaccination is not recommended in the Netherlands, but it is in other countries.[36] Varicella infection occurs at a younger age in the Netherlands compared to other countries.”
BackgroundSelf-citation
Research works printed but not linked: 1
- McLean HQ PFA, Temte JL, Wallace GS (2013) Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013: Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62: 1– 34. 23760231
Cited by
Wilcox, C. R., Holder, B., & Jones, C. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01294 · Cited by 200
“It follows therefore that a reduced transfer of IgG in pre-term infants compared with term infants has been demonstrated for a variety of pathogens (127) (97) (128) particularly for infants born at less than 36 weeks of gestation (126).”
BackgroundVertically Transferred Immunity in Neonates: Mothers, Mechanisms and Mediators
Albrecht, M., & Arck, P. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00555 · Cited by 199
“infants Prospective observational study 138 (59)”
Maternal immunisation: collaborating with mother nature
Marchant, A., Sadarangani, M., Garand, M., Dauby, N., Verhasselt, V., Pereira, L., Bjornson, G., Jones, C. E., Halperin, S. A., Edwards, K. M., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30229-3 · Cited by 183
Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease
Mahadevan, U., Vermeire, S., Lasch, K. L., Abhyankar, B., Bhayat, F., Blake, A., & Dubinsky, M. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13960 · Cited by 132
“As a result, it has been demonstrated that there are significantly lower levels of seroprotection to vaccine-preventable diseases, such as measles, mumps and rubella, in pre-term compared with full-term infants.(36) At term, foetal IgG levels typically”
BackgroundImmunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future
Schüller, S. S., Kramer, B. W. W., Villamor, E., Spittler, A., Berger, A., & Levy, O. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00199 · Cited by 78
Maternal immunization: Optimizing protection for the mother and infant
Kachikis, A. B., & Englund, J. A. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.04.027 · Cited by 65
Benedetto, M. G. D., Bottanelli, C., Cattaneo, A., Pariante, C. M., & Borsini, A. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.05.032 · Cited by 62
Atwell, J. E., Thumar, B., Robinson, L. J., Tobby, R., Yambo, P., Ome-Kaius, M., Siba, P. M., Unger, H. W., Rogerson, S. J., King, C. L., et al. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv401 · Cited by 48
Atwell, J. E., Lutz, C. S., Sparrow, E. G., & Feikin, D. R. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.034 · Cited by 51
Scheltema, N. M., Kavelaars, X., Thorburn, K., Hennus, M. P., van Woensel, J. B. M., van der Ent, C. K., Borghans, J. A. M., Bont, L., & Drylewicz, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.06.021 · Cited by 42
“As transplacental antibody transfer becomes efficient only from the third trimester of pregnancy onward, maternal vaccination may provide limited protection for preterm infants [18–20].”
Meng, Q., Liu, Y., Yu, J., Li, L., Shi, W., Shen, Y., Li, L., Zhan, S., Yang, F., Wang, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31283-y · Cited by 41
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes
Phijffer, E. W. E. M., de Bruin, O., Ahmadizar, F., Bont, L., der Maas, N. A. V., Sturkenboom, M., Wildenbeest, J., & Bloemenkamp, K. W. M. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015134.pub2 · Cited by 76
Wei, X., Yang, J., Gao, L., Wang, L., Liao, Q., Qiu, Q., Luo, K., Yu, S., Zhou, Y., Liu, F., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30480-1 · Cited by 33
Voordouw, B. C. G., Rockx, B., Jaenisch, T., Fraaij, P. L. A., Mayaud, P., Vossen, A. C. T. M., & Koopmans, M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00130-18 · Cited by 35
Plans, P., de Ory, F., Campins, M., Álvarez, E., Payà, A., Guisasola, M. E., Compte, C., Vellbé, K., Sánchez, C. M. B., Lozano, M., et al. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2339-4 · Cited by 35
Rubella seroprevalence among pregnant women in Beijing, China
Meng, Q., Luo, J., Li, L., Shi, W., Yu, J., Shen, Y., Li, L., Wang, Y., & Yao, K. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3032-x · Cited by 23
“International assigned cut-off values of ≥10 IU/ml were used to assess the percentage of pregnant women with protective IgG concentrations, according to previous reports [24, 25].”
MethodRenesme, L. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.10.005 · Cited by 25
Who's the Target: Mother or Baby?
Kachikis, A. B., Eckert, L. O., & Englund, J. A. (2018) · Viral Immunology · doi:10.1089/vim.2017.0135 · Cited by 22
“These include IgG subtype produced following vaccination, timing of the vaccine, fetal gestational age, placental integrity, and total maternal IgG levels (44,83,101).”
In utero priming of fetal immune activation: Myths and mechanisms
Vidal, M. S., & Menon, R. (2023) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2023.103922 · Cited by 18
Immunization Completion in Infants Born at Low Birth Weight
Nestander, M., Dintaman, J. M., Susi, A., Gorman, G. H., & Hisle-Gorman, E. J. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix079 · Cited by 20
Malshe, N. S., Palkar, S. H., Kulkarni, R., Lalwani, S. K., Mishra, A. C., & Arankalle, V. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.043 · Cited by 17
Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm
Kachikis, A. B., Pike, M., Eckert, L. O., Roberts, E. A., Frank, Y., Young, A. L., Goecker, E. A., Gravett, M. G., Greninger, A. L., & Englund, J. A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.52387 · Cited by 17
Prevention and management of VZV infection during pregnancy and the perinatal period
Charlier, C., Anselem, O., Caséris, M., Lachâtre, M., Tazi, A., Driessen, M., Pinquier, D., Cœur, C. L., Saunier, A., Bergamelli, M., et al. (2024) · Infectious Diseases Now · doi:10.1016/j.idnow.2024.104857 · Cited by 15
Why Should We Advocate Maternal Immunization?
Boonyaratanakornkit, J. B., & Chu, H. Y. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002312 · Cited by 20
Vauloup‐Fellous, C. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.10.004 · Cited by 16
Khampanisong, P., Pauly, M., Nouanthong, P., Vickers, M. A., Virachith, S., Xaydalasouk, K., Black, A. P., Muller, C. P., & Hübschen, J. M. (2021) · Pathogens · doi:10.3390/pathogens10101316 · Cited by 13
“Gestational age of the child, maternal nutrition, as well as maternal vaccination and infection status determine the level of antibodies passively acquired by the child and as a result the duration of post-natal protection [5,6].”
BackgroundSchlindwein, C. F., Perin, M. C. A. A., de Moraes‐Pinto, M. I., Simão-Gurge, R. M., Goulart, A. L., Weckx, L. Y., & dos Santos, A. M. N. (2018) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2017.12.001 · Cited by 12
Damjanovic, A. K., Styer, L. M., Nemeth, K. L., Yauney, E., Rock, J. M., Bievenue, R., Hoen, R., Ehrbar, D. J., Kay, D. M., Caggana, M., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.27995 · Cited by 12
Kayatani, A. K. K., Leke, R. G. F., Leke, R. I. J., Fogako, J., & Taylor, D. W. (2022) · Scientific Reports · doi:10.1038/s41598-022-21908-8 · Cited by 10
Sartoretti, J., & Eberhardt, C. S. (2021) · Vaccines · doi:10.3390/vaccines9040306 · Cited by 11
“The cumulative transfer of maternal antibodies over time is also underlined by the lower antibody titers found in preterm compared to term infants [47,48].”
BackgroundKhorrami, S. M. S., Mokhtari‐Azad, T., Yavarian, J., Nasab, G. S. F., Naseri, M., & Shafiei-Jandaghi, N.-Z. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24250 · Cited by 9
“IgG avidity is low in a primary antigenic challenge but raises gradually due to maturation [van den Berg et al., 2014].”
BackgroundRespiratory syncytial virus vaccination during pregnancy for improving infant outcomes
Phijffer, E. W. E. M., de Bruin, O., Wildenbeest, J., Bont, L., Sturkenboom, M., der Maas, N. A. V., Ahmadizar, F., & Bloemenkamp, K. W. M. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015134 · Cited by 10
Brebant, D., Couffignal, C., Manchon, P., Duquesne, S., Picone, O., & Vauloup‐Fellous, C. (2023) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105495 · Cited by 8
“Thus, transfer ratio (TR) of maternal antibodies is reported to be negatively impacted by prematurity [6].”
Keij, F. M., Achten, N. B., Tramper‐Stranders, G. A., Allegaert, K., van Rossum, A. M. C., Reiss, I. K. M., & Kornelisse, R. F. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.590969 · Cited by 9
“Earlier vaccination, during the second trimester, would be needed to protect preterm neonates, although transplacental antibody transport is reduced before the third trimester, resulting in lower anti body concentrations in general following preterm birth (61).”
BackgroundGut microbiome dysbiosis in neonatal sepsis
Verma, J. K., Sankar, M. J., Atmakuri, K., Agarwal, R. K., & Das, B. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.010 · Cited by 6
Rumfelt, K. E., Englund, J. A., & Kachikis, A. B. (2025) · Women s Health · doi:10.1177/17455057251338501 · Cited by 9
Li, M., Zhang, W., Zheng, S., Guo, J., He, H., Ma, Y., Huang, Y. H., Feng, Y., & Ji, C. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2338505 · Cited by 4
“28,29 There was evidence that the geometric mean titer of measles antibodies in PT was 1.7–2.5 times lower than that in FT, which indicated that the protective effect of maternal antibodies in PT was obviously weak before MCV vaccination.”
BackgroundInfluentialKayatani, A. K. K., Bobbili, N., Megnekou, R., Matsunaga, M., Leke, R. F. G., & Taylor, D. W. (2023) · Placenta · doi:10.1016/j.placenta.2023.07.011 · Cited by 3
Tamura, K., Matsumura, K., Tsuchida, A., Yoshida, T., Inadera, H., The Japan Environment and Children’s Study (JECS) Group, Kamijima, M., Yamazaki, S., Ohya, Y., Kishi, R., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-26748-0 · Cited by 8
Seroprevalence of Measles in Pairs of Mothers and Newborns in Southern Greece
Barmpakou, A., Mavrouli, M. D., Pana, A., Kourkouni, Ε., Panagiotou, I., Spanakis, N., & Michos, A. G. (2023) · Viral Immunology · doi:10.1089/vim.2023.0047 · Cited by 3
“…gestational age, maternal age, history of vaccination or disease, co-morbidities, and underlying diseases of the mother, maternal nutrition, prevalence of measles in the setting where a child is born, parity, and placental disease (Ray et al., 2019; Van Den Berg et al., 2014; Wilcox et al., 2017).”
Martínez-Quezada, R., Valencia-Ledezma, O. E., Ramírez-Lozada, T., Miguel-Rodríguez, C. E., Fernández-Hernández, J. C., & Acosta‐Altamirano, G. (2024) · Vaccines · doi:10.3390/vaccines12080860 · Cited by 4
“…preterm birth has been associated with a decreased efficiency of the placental transfer of antibodies against a wide variety of viruses, including those against measles, mumps, chickenpox, rubella, influenza, diphtheria, pertussis, tetanus, polio, and respiratory syncytial viruses [19,28–32].”
BackgroundResultThe immune system of preterm infants: an overview
Esser, M. J., Claassen, S. J. C. M., Ebrahimi, M. P., Berkers, S., Wolfs, T. G. A. M., Berkowska, M. A., Driessen, G. J. A., & Bijker, E. M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1810170 · Cited by 5
Ghafourian, M., Shakurnia, A., Alavi, S. M., Kooti, W., Shakerinejad, G., Serajian, A., & Chinipardaz, Z. (2015) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.27896 · Cited by 2
“Maternal antibody (IgG) is transmitted to the fetus through placenta during pregnancy, making infants immune in the first few months of life (3).”
BackgroundAnas, M., Batool, S., Usman, M., Ullah, N., Salman, M., Umair, M., Alam, M. M., Mahmood, N., Javaid, E., Shahzadi, T., et al. (2025) · Pediatric Infectious Disease · doi:10.5005/jp-journals-10081-1500 · Cited by 1
Γραμμενιάτης, Α., Burriel, A. R., Pappa, K. I., & Ioannidis, A. (2022) · Journal of Clinical Obstetrics & Gynecology · doi:10.5336/jcog.2021-87370 · Cited by 1
Empfehlungen 2015/2016 der Ständigen Impfkommission
Kowalzik, F., & Zepp, F. (2016) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-016-0177-9 · Cited by 1
“SSW besitzen nur sehr niedrigere VZV-Antikörper-Konzentrationen, da erst ab etwa dieser Gestationswoche IgG aktiv von der Mutter zum ungeborenen Kind transferiert wird [16, 17].”
BackgroundCzajka, H., Lauterbach, R., Pawlik, D., & Radziszewska, R. (2017) · Pediatria Polska · doi:10.1016/j.pepo.2017.05.008 · Cited by 1
Crooke, S. N., Coughlin, M. M., & Perelygina, L. M. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0090 · Cited by 1
Update: Impfempfehlungen für Kinder und Jugendliche
Kowalzik, F., & Zepp, F. (2019) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-019-0652-1
Charlier, C., Anselem, O., Caséris, M., Lachâtre, M., Tazi, A., Driessen, M., Pinquier, D., Cœur, C. L., Saunier, A., Bergamelli, M., et al. (2025) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2025.01.001
Crooke, S. N., Coughlin, M. M., & Perelygina, L. M. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0090
Damjanovic, A. K., Keyel, A. C., Rock, J. M., Ehrbar, D. J., Bievenue, R., Nemeth, K. L., Yauney, E., Kay, D. M., Caggana, M., Parker, M. M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-09140-6
“Furthermore, shorter N IgG half-life estimates in infants of earlier gestational age (Table 3) may be explained by a lower transplacental transfer of maternal antibodies, as previously reported 36,37 .”
Standardized vaccination practices for preterm infants: Egyptian experts’ consensus
Beleidy, A. E., Ghandour, M. A. A. E., Reyad, A., Edris, A. A. F., Samy, G., Abdel‐Hady, H., Awad, H. A., Abdelkhalek, K., El‐Saied, M. M., Omar, M., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12243-0 · Cited by 2
Mikkelsen, S. D., Fisker, A. B., Nebie, E. I., Zakane, S. A., Sie, A. B., Coulibaly, B., Trans, K. L., Jensen, K. J., Pedersen, M., Tolstrup, J. S., et al. (2026) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2026.104979
Metadata
- Authors
- van den Berg, J. P., Westerbeek, E. A. M., Smits, G. P., van der Klis, F. R. M., Berbers, G. A. M., & van Elburg, R. M.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- National Institute for Public Health and the Environment (NL)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-11
- Volume
- 9
- Issue
- 4
- Pages
- e94714
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3984210
- OpenAlex
- W2003449245
- Cited by
- 54
- References
- 53
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 4
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Funders
- Danone
- Vrije Universiteit Amsterdam
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and Maternal Infections
- Keywords
- transplacental antibody transfer, preterm infants, very preterm infants, measles, mumps, rubella, varicella zoster, maternal antibodies, umbilical cord blood, term infants, neonatal immunity
- MeSH terms
- Adult, Antibodies, Viral, Chickenpox, Female, Humans, Immunoglobulin G, Immunity, Maternally-Acquired, Infant, Newborn, Infant, Premature, Measles, Mumps, Placenta, Pregnancy, Rubella virus, Seroepidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

